Home › Funds › Champlain Investment Partners, LLC › RGEN

Champlain Investment Partners, LLC position in RGEN

Repligen Corp · Health Care

Champlain Investment Partners, LLC reported holding 249,195 shares of RGEN (Repligen Corp) in its Q3 2026 13F filing — a position valued at US$47.9M, representing 1.65% of its reported portfolio and ranking #5 among its reported holdings. Champlain Investment Partners, LLC has disclosed RGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)249.19K sh
Reported value held$47.90M
Portfolio Weight1.65%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Champlain Investment Partners, LLC's RGEN position evolved

Champlain Investment Partners, LLC first disclosed a stake in RGEN in Q3 2023 at 855,190 shares (US$136.0M). The position peaked in Q4 2024 at 1,543,530 shares, worth US$222.2M. Across 13 filings, Champlain Investment Partners, LLC increased the stake 3 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 249,195 shares valued at US$47.9M — a reduction of -69,760 shares quarter over quarter.. Notable position changes include a 38% trim in Q1 2024 (shares fell 31% over the following quarter), a 149% increase in Q3 2024 (shares fell 3% over the following quarter), a 54% trim in Q2 2026 (shares rose 41% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 855.19K $135.98M New
Q4 2023 926.44K $166.57M Add
Q1 2024 575.00K $105.75M Reduce
Q2 2024 570.59K $71.93M Reduce
Q3 2024 1.42M $211.46M Add
Q4 2024 1.54M $222.18M Add
Q1 2025 1.46M $186.28M Reduce
Q2 2025 1.40M $174.27M Reduce
Q3 2025 1.34M $179.02M Reduce
Q4 2025 1.00M $164.51M Reduce
Q1 2026 693.86K $81.75M Reduce
Q2 2026 318.95K $43.52M Reduce
Q3 2026 249.19K $47.90M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (Repligen Corp) is a Health Care company. 33 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has Champlain Investment Partners, LLC held RGEN?

Champlain Investment Partners, LLC has disclosed RGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Champlain Investment Partners, LLC's current position in RGEN?

As of Q3 2026, Champlain Investment Partners, LLC holds 249.19K shares of RGEN (Repligen Corp), valued at $47.90M, representing 1.65% of its reported portfolio and ranking #5.

Has Champlain Investment Partners, LLC been buying or selling RGEN?

In the latest 13F filing (Q3 2026), Champlain Investment Partners, LLC reduced its position in RGEN. The position peaked in Q4 2024 at 1.54M shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.